Stryker Charged with Marketing Fraud

Courtesy MedPage Today Surgery  Thu, 10/29/2009 - 12:49

Stryker Corp.'s biotech division and four current and former executives have been indicted on federal fraud charges related to their marketing of two bone-growth products.


 

More related items

Spine Surgeons React to BMP-2 Cancer Data
CHICAGO (MedPage Today) -- Spine surgery patients who got a bone growth stimulating agent as part of a clinical trial were three to five times more likely to develop cancer two to three years...

Sunscreen must protect against UVA and UVB rays or...
FDA will also prohibit sunscreen marketing claims like 'waterproof' and 'sweatproof,' which the agency said 'are exaggerations of performance.'

Botox maker to pay $600M to resolve investigation
WASHINGTON (AP) -- Allergan Inc., the maker of wrinkle-smoothing Botox, says it will pay $600 million to settle a yearslong federal investigation into its marketing of the top-selling,...

Country Save HE Laundry Detergent, Powder, 160-Load,...

Yogi Tea Calm, Bedtime, Tea Bags, 16-Count Boxes...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
health-fitness.marc8.com